Columbus Hill Capital Management, L.P. Bristol Myers Squibb CO Transaction History

Columbus Hill Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $30.1 Million - $35.9 Million	-666,989 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $1.99 Million - $2.58 Million	-40,775 Reduced 5.76%	666,989 $34.7 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $240,738 - $271,534	-4,362 Reduced 0.61%	707,764 $43.9 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $6.61 Million - $8.24 Million	130,894 Added 22.52%	712,126 $39.4 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $605,192 - $696,698	10,100 Added 1.77%	581,232 $36.8 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $4.46 Million - $4.86 Million	-74,400 Reduced 11.53%	571,132 $35 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $35.7 Million - $41.1 Million	645,532	645,532 $41.1 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Columbus Hill Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Columbus Hill Capital Management, L.P. with notifications on news.